Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2019

Sep 5, 2019

30786_dirs_2019-09-05_4ca886fd-e94c-4264-a9c1-243ddaa373fc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-03

Reporting Person: HUTTON RONALD W (Vice President and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-04 Bio-Rad A Common Stock M 180 Acquired 4205.9448 Direct
2019-09-04 Bio-Rad A Common Stock F 63 $335.20 Disposed 4142.9448 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-03 Restricted Stock Units $0 A 774 Acquired Bio-Rad A Common Stock (774) Direct
2019-09-04 Restricted Stock Units $0 M 180 Disposed Bio-Rad A Common Stock (180) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Includes 6.3045, 6.7317, 7.9962 and 5.2888 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 9/28/18, 12/31/18, 3/29/19 and 6/28/19, respectively.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F5: The restricted stock units vest in five equal annual installments beginning September 4, 2019.